Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study

Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study

Objective(s): Phage therapy is a potential alternative treatment for infections caused by Acinetobacter baumannii, a significant nosocomial pathogen, which has evolved resistance to almost all conventional antimicrobial drugs in poor hygiene and conflicts areas such as Iraq. Materials and Methods: B...

Full description

Bibliographic Details
Main Authors:	Hayder Nsaif Jasim, Rand Riadh Hafidh, Ahmed Sahib Abdulamir
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2018-11-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	Acinetobacter baumannii Bacteriophages Drug resistance Endolysin Phage therapy
Online Access:	http://ijbms.mums.ac.ir/article_11603_71ca2a6cfc1d8676dc03bf3027c5ecff.pdf

Similar Items

The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage
by: Behnam Sisakhtpour, et al.
Published: (2022-01-01)

Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage ØABP-01 endolysin (LysABP-01) in combination with colistin
by: Rapee Thummeepak, et al.
Published: (2016-09-01)

Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Kyeongmin Kim, et al.
Published: (2021-09-01)

A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
by: Fazal Mehmood Khan, et al.
Published: (2021-03-01)

A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
by: Minle Wu, et al.
Published: (2019-01-01)

Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
by: Minle Wu, et al.
Published: (2019-02-01)

Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant <em>Acinetobacter baumannii</em>
by: Yujing Tan, et al.
Published: (2022-12-01)

Acinetobacter Baumannii Phages: Past, Present and Future
by: Qihang Tu, et al.
Published: (2023-03-01)

Investigation of the Characteristics of Multidrug-Resistant (MDR) Acinetobacter Baumannii Lytic Phage Isolated from the Intensive Care Unit
by: Behnam Sisakhtpour, et al.
Published: (2019-08-01)

Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
by: Shukho Kim, et al.
Published: (2020-09-01)

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022-01-01)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
by: Hasan Ghajavand, et al.
Published: (2017-01-01)

Isolation and characterization of ZZ1, a novel lytic phage that infects <it>Acinetobacter baumannii</it> clinical isolates
by: Jin Jing, et al.
Published: (2012-07-01)

Phage-Encoded Endolysins
by: Fatma Abdelrahman, et al.
Published: (2021-01-01)

Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent
by: Ia Kusradze, et al.
Published: (2016-10-01)

Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-Gram-negative bacterial activity
by: Hugo eOliveira, et al.
Published: (2016-02-01)

Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study
by: Li-Kuang Chen, et al.
Published: (2022-05-01)

Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandi, et al.
Published: (2022-11-01)

Two New Lytic Bacteriophages of the Myoviridae Family Against Carbapenem-Resistant Acinetobacter baumannii
by: Weilong Zhou, et al.
Published: (2018-04-01)

Characterization of Virulent T4-Like <i>Acinetobacter baumannii</i> Bacteriophages DLP1 and DLP2
by: Danielle L. Peters, et al.
Published: (2023-03-01)

Bacteriophages, phage endolysins and antimicrobial peptides – the possibilities for their common use to combat infections and in the design of new drugs
by: Tomasz Mirski, et al.
Published: (2019-06-01)

Isolation and Characterization of a Novel <i>Siphoviridae</i> Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Meity Mardiana, et al.
Published: (2022-06-01)

Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200
by: Yannan Liu, et al.
Published: (2019-01-01)

Treatment of Acinetobacter baumannii by Specialized ϕTZ Bacteriophage and Studying of pH Effect on Bacteriophage Stability and Efficacy
by: Taha Yaseen Ibrahim
Published: (2022-12-01)

Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia
by: Jongsoo Jeon, et al.
Published: (2019-04-01)

Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant Acinetobacter baumannii
by: Goran Vukotic, et al.
Published: (2020-08-01)

Novel phage lysin Abp013 against Acinetobacter baumannii
by: Chu, Joash Jun Keat, et al.
Published: (2022)

Identification of a Novel Acinetobacter baumannii Phage-Derived Depolymerase and Its Therapeutic Application in Mice
by: Can Wang, et al.
Published: (2020-07-01)

Characterization of a Straboviridae phage vB_AbaM-SHI and its inhibition effect on biofilms of Acinetobacter baumannii
by: Liming Jiang, et al.
Published: (2024-03-01)

Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study
by: Fernando L. Gordillo Altamirano, et al.
Published: (2022-06-01)

Thousands of Novel Endolysins Discovered in Uncultured Phage Genomes
by: Iris Fernández-Ruiz, et al.
Published: (2018-05-01)

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant <i>Acinetobacter baumannii</i>, including in Human and Poultry
by: Yan Zhang, et al.
Published: (2022-10-01)

Comparative Analysis of 37 Acinetobacter Bacteriophages
by: Dann Turner, et al.
Published: (2017-12-01)

The Specific Capsule Depolymerase of Phage PMK34 Sensitizes <i>Acinetobacter baumannii</i> to Serum Killing
by: Karim Abdelkader, et al.
Published: (2022-05-01)

Characterization and efficacy against carbapenem-resistant Acinetobacter baumannii of a novel Friunavirus phage from sewage
by: Zhitao Wang, et al.
Published: (2024-04-01)

Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii
by: Md Maidul Islam, et al.
Published: (2022-09-01)

Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii
by: Nisha Rathor, et al.
Published: (2023-01-01)

Characterization of Novel Lytic <em>Myoviridae</em> Phage Infecting Multidrug-Resistant <em>Acinetobacter baumannii</em> and Synergistic Antimicrobial Efficacy between Phage and Sacha Inchi Oil
by: Phitchayapak Wintachai, et al.
Published: (2022-02-01)

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
by: Nannan Wu, et al.
Published: (2021-01-01)

Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
by: Xin Tan, et al.
Published: (2021-02-01)